|Publication number||US20050021106 A1|
|Application number||US 10/913,034|
|Publication date||27 Jan 2005|
|Filing date||6 Aug 2004|
|Priority date||13 Jul 2000|
|Also published as||US7236831, US20040073270, US20090118788|
|Publication number||10913034, 913034, US 2005/0021106 A1, US 2005/021106 A1, US 20050021106 A1, US 20050021106A1, US 2005021106 A1, US 2005021106A1, US-A1-20050021106, US-A1-2005021106, US2005/0021106A1, US2005/021106A1, US20050021106 A1, US20050021106A1, US2005021106 A1, US2005021106A1|
|Inventors||Andrew Firlik, Jeffrey Balzer, Bradford Gliner|
|Original Assignee||Firlik Andrew D., Jeffrey Balzer, Gliner Bradford Evan|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (94), Referenced by (31), Classifications (25), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation-in-part of U.S. application Ser. No. 10/260,720, filed on Sep. 27, 2002, which claims the benefit of U.S. application Ser. No. 60/325,872 filed on Sep. 28, 2001 and which is a continuation-in-part of U.S. application Ser. No. 09/802,808, filed on Mar. 8, 2001, which, in turn, claims the benefit of U.S. Provisional Application No. 60/217,981, filed Jul. 31, 2000. Each of these applications is incorporated by reference herein in its entirety.
Several embodiments of methods and apparatus in accordance with the invention are related to electrically stimulating a region in the cortex or other area of the brain to bring about a lasting change in a physiological function and/or a mental process of a patient.
A wide variety of mental and physical processes are controlled or influenced by neural activity in particular regions of the brain. The neural-functions in some areas of the brain (i.e., the sensory or motor cortices) are organized according to physical or cognitive functions. Several other areas of the brain also appear to have distinct functions in most individuals. In the majority of people, for example, the occipital lobes relate to vision, the left interior frontal lobes relate to language, and the cerebral cortex appears to be involved with conscious awareness, memory, and intellect.
Many problems or abnormalities can be caused by damage, disease and/or disorders in the brain. Effectively treating such abnormalities may be very difficult. For example, a stroke is a common condition that damages the brain. Strokes are generally caused by emboli (e.g., obstruction of a vessel), hemorrhages (e.g., rupture of a vessel), or thrombi (e.g., clotting) in the vascular system of a specific region of the brain. Such events generally result in a loss or impairment of a neural function (e.g., neural functions related to facial muscles, limbs, speech, etc.). Stroke patients are typically treated using various forms of physical therapy to rehabilitate the loss of function of a limb or another affected body part. Stroke patients may also be treated using physical therapy plus an adjunctive therapy such as amphetamine treatment. For most patients, however, such treatments are minimally effective and little can be done to improve the function of an affected body part beyond the recovery that occurs naturally without intervention.
The problems or abnormalities in the brain are often related to electrical and/or chemical activity in the brain. Neural activity is governed by electrical impulses or “action potentials” generated in neurons and propagated along synaptically connected neurons. When a neuron is in a quiescent state, it is polarized negatively and exhibits a resting membrane potential typically between −70 and −60 mV. Through chemical connections known as synapses, any given neuron receives excitatory and inhibitory input signals or stimuli from other neurons. A neuron integrates the excitatory and inhibitory input signals it receives, and generates or fires a series of action potentials when the integration exceeds a threshold potential. A neural firing threshold, for example, may be approximately −55 mV.
It follows that neural activity in the brain can be influenced by electrical energy supplied from an external source such as a waveform generator. Various neural functions can be promoted or disrupted by applying an electrical current to the cortex or other region of the brain. As a result, researchers have attempted to treat physical damage, disease and disorders in the brain using electrical or magnetic stimulation signals to control or affect brain functions.
Transcranial electrical stimulation is one such approach that involves placing an electrode on the exterior of the scalp and delivering an electrical current to the brain through the scalp and skull. Another treatment approach, transcranial magnetic stimulation, involves producing a high-powered magnetic field adjacent to the exterior of the scalp over an area of the cortex. Yet another treatment approach involves direct electrical stimulation of neural tissue using implanted electrodes.
The neural stimulation signals used by these approaches may comprise a series of electrical or magnetic pulses that can affect neurons within a target neural population. Stimulation signals may be defined or described in accordance with stimulation signal parameters including pulse amplitude, pulse frequency, duty cycle, stimulation signal duration, and/or other parameters. Electrical or magnetic stimulation signals applied to a population of neurons can depolarize neurons within the population toward their threshold potentials. Depending upon stimulation signal parameters, this depolarization can cause neurons to generate or fire action potentials. Neural stimulation that elicits or induces action potentials in a functionally significant proportion of the neural population to which the stimulation is applied is referred to as supra-threshold stimulation; neural stimulation that fails to elicit action potentials in a functionally significant proportion of the neural population is defined as sub-threshold stimulation. In general, supra-threshold stimulation of a neural population triggers or activates one or more functions associated with the neural population, but sub-threshold stimulation by itself does not trigger or activate such functions. Supra-threshold neural stimulation can induce various types of measurable or monitorable responses in a patient. For example, supra-threshold stimulation applied to a patient's motor cortex can induce muscle fiber contractions in an associated part of the body.
Although electrical or magnetic stimulation of neural tissue may be directed toward producing an intended type of therapeutic, rehabilitative, or restorative neural activity, such stimulation may result in collateral neural activity. In particular, neural stimulation delivered beyond a certain intensity, period of time, level, or amplitude can give rise to seizure activity and/or other types of collateral activity. It will be appreciated that collateral neural activity may be undesirable and/or inconvenient in a neural stimulation situation.
The human brain has two hemispheres that are connected via the corpus callosum. Each hemisphere of the brain generally exerts majority control over motor functions and/or sensory functions on the opposite or “contralateral” side of the patient's body. Hence, for example, the left hemisphere of the brain has majority control over movement of the right arm and right leg. Through transcallosal connections, though, each hemisphere of the brain exerts some degree of control over the functions on the same or “ipsilaterial” side of the patient's body. Hence, the right hemisphere of the brain may have some involvement in controlling movement of the right arm and right leg.
Some studies have concluded that damage to or disorders of the cerebral cortex on one hemisphere can induce long-term changes in the structure and function of a homotopic location of the contralateral hemisphere, namely a location on the undamaged cortex that is at about the same position as the position of the damaged tissue in the opposite cortex. Damage to the cortex in one hemisphere may impact the contralateral homotopic cortex in a variety of fashions, including causing increased cortical thickness, dendritic growth and/or elimination, neuronal hyperexcitability, and synaptogenesis. See, e.g., Nudo, “Recovery After Damage to Motor Cortical Areas,” Current Opinion in Neurobiology, 1999, 9:740-747, the entirety of which is incorporated herein by reference. See also Keyvani et al., “Suppression of Proteasome C2 Contralateral to Ischemic Lesions in Rat Brain,” Brain Research 858, (2000) 386-392.
The following disclosure describes several methods and apparatus for intracranial electrical stimulation to treat or otherwise effectuate a change in neural-functions of a patient. Several embodiments of methods in accordance with the invention are directed toward enhancing or otherwise inducing neuroplasticity to effectuate a particular neural-function. Neuroplasticity refers to the ability of the brain to change or adapt over time. It was once thought adult brains became relatively “hard wired” such that functionally significant neural networks could not change significantly over time or in response to injury. It has become increasingly more apparent that these neural networks can change and adapt over time so that meaningful function can be regained in response to brain injury. An aspect of several embodiments of methods in accordance with the invention is to provide the appropriate triggers for adaptive neuroplasticity. These appropriate triggers appear to cause or enable increased synchrony of functionally significant populations of neurons in a network.
Electrically enhanced or induced neural stimulation in accordance with several embodiments of the invention excites a portion of a neural network involved in a functionally significant task such that a selected population of neurons can become more strongly associated with that network. Because such a network will subserve a functionally meaningful task, such as motor relearning, the changes are more likely to be lasting because they are continually being reinforced by natural use mechanisms. The nature of stimulation in accordance with several embodiments of the invention ensures that the stimulated population of neurons links to other neurons in the functional network. It is expected that this occurs because action potentials are not actually caused by the stimulation, but rather are caused by interactions with other neurons in the network. Several aspects of the electrical stimulation in accordance with selected embodiments of the invention simply allows this to happen with an increased probability when the network is activated by favorable activities, such as rehabilitation or limb use.
The methods in accordance with the invention can be used to treat brain damage (e.g., stroke, trauma, etc.), brain disease (e.g., Alzheimer's, Pick's, Parkinson's, etc.), and/or brain disorders (e.g., epilepsy, depression, etc.). The methods in accordance with the invention can also be used to enhance functions of normal, healthy brains (e.g., learning, memory, etc.), or to control sensory functions (e.g., pain).
Certain embodiments of methods in accordance with the invention electrically stimulate the brain at a stimulation site where neuroplasticity is occurring. The stimulation site may be different than the region in the brain where neural activity is typically present to perform the particular function according to the functional organization of the brain. In one embodiment in which neuroplasticity related to the neural-function occurs in the brain, the method can include identifying the location where such neuroplasticity is present. This particular procedure may accordingly enhance a change in the neural activity to assist the brain in performing the particular neural function. In an alternative embodiment in which neuroplasticity is not occurring in the brain, an aspect is to induce neuroplasticity at a stimulation site where it is expected to occur. This particular procedure may thus induce a change in the neural activity to instigate performance of the neural function. Several embodiments of these methods are expected to produce a lasting effect on the intended neural activity at the stimulation site.
The specific details of certain embodiments of the invention are set forth in the following description and in
1. Embodiments of Electrically Enhancing Neural Activity
The method 100 includes a diagnostic procedure 102 involving identifying a stimulation site. In one approach, the stimulation site may be a location of the brain where an intended neural activity related to the neural-function is or is expected to be present. In another approach, the stimulation site may be a location of the brain that supports or is expected to support the intended neural-function.
The diagnostic procedure 102 may include identifying one or more exterior anatomical landmarks on the patient that correspond to such neurological regions and/or structures within the brain. The external anatomical landmarks serve as reference points for locating a structure of the brain where an intended neural activity may occur. Thus, one aspect of the diagnostic procedure 102 may include referencing the stimulation site on the brain relative to external anatomical landmarks.
More specifically, identifying an anatomical landmark may include visually determining the location of one or more reference structures (e.g., visible cranial landmarks), and locating underlying brain regions or structures (e.g., the motor strip and/or the Sylvian fissure) relative to the external location of the reference structures in a manner understood by those skilled in the art. Such reference structures may include, for example, the bregma, the midsagittal suture, and/or other well-known cranial landmarks. The methods for locating the underlying brain structure typically involve measuring distances and angles relative to the cerebral topography as known in the art of neurosurgery.
In another embodiment, the diagnostic procedure 102 includes generating the intended neural activity in the brain from a “peripheral” location that is remote from the normal location, and then determining where the intended neural activity is actually present in the brain. In an alternative embodiment, the diagnostic procedure 102 can be performed by identifying a stimulation site where neural activity has changed in response to a change in the neural-function. For example, the patient's brain may be scanned for neural activity associated with the impaired neural-function as the patient regains use of an affected limb or learns a task over a period of time. In yet another embodiment, the diagnostic procedure 102 may involve identifying a stimulation site where a corollary neural activity is present. This corollary neural activity may correspond to an unaffected or unimpaired physiological function or mental process that is a counterpart or corollary to an impaired or affected physiological function or mental process, e.g., movement of an unimpaired limb that is contralateral to an impaired homotypic limb.
The method 100 continues with an implanting procedure 104 involving positioning first and second electrodes relative to the identified stimulation site, and a stimulating procedure 106 involving applying an electrical current between the first and second electrodes. Many embodiments of the implanting procedure 104 position two or more electrodes at the stimulation site, but other embodiments of the implanting procedure involve positioning only one electrode at the stimulation site and another electrode remotely from the stimulation site. As such, the implanting procedure 104 of the method 100 can include implanting at least one electrode at the stimulation site. The procedures 102-106 are described in greater detail below.
The brain 200 of
The neural activity in the first region 210, however, can be impaired. In one embodiment, the diagnostic procedure 102 begins by taking an image of the brain 200 that is capable of detecting neural activity to determine whether the intended neural activity associated with the particular neural function of interest is occurring at the region of the brain 200 where it normally occurs according to the functional organization of the brain.
The two hemispheres 202 and 204 of the brain 200 are connected via the corpus callosum, which facilitates information transfer between the hemispheres 202 and 204. Although each hemisphere 202 or 204 generally exerts majority control over motor and/or sensory functions on the opposite or contralateral side of the patient's body, each hemisphere typically also exerts some level of control and/or influence over motor and/or sensory functions on the same or ipsilateral side of the patient's body. Moreover, through transcallosal connections, neural activity in one hemisphere may influence neural activity, e.g., neuroplasticity, in the opposite hemisphere. The location in the brain 200 that exerts influence on an ipsilateral body function frequently is proximate to or subsumed within the location of the brain associated with a corollary body function. Hence, as suggested in
The diagnostic procedure 102 may utilize the neuroplasticity that occurs in the brain to identify the location of a stimulation site that is expected to be more responsive to the results of an electrical, magnetic, sonic, genetic, biologic, and/or pharmaceutical procedure to effectuate the desired neural-function. One embodiment of the diagnostic procedure 102 involves generating the intended neural activity remotely from the first region 210 of the brain, and then detecting or sensing the location in the brain where the intended neural activity has been generated. The intended neural activity can be generated by applying an input that causes a signal to be sent to the brain. For example, in the case of a patient having an impaired limb, the affected limb is moved and/or stimulated while the brain is scanned using a known imaging technique that can detect neural activity (e.g., functional MRI, positron emission tomography, etc.). In one specific embodiment, the affected limb can be moved by a practitioner or the patient, stimulated by sensory tests (e.g., pricking), or subject to peripheral electrical stimulation. The movement/stimulation of the affected limb produces a peripheral neural signal from the limb that is expected to generate a response neural activity in the brain. The location in the brain where this response neural activity is present can be identified using the imaging technique.
Several particular embodiments for peripherally generating the intended neural activity are expected to be useful for therapies that involve patients who have lost volitional control of a body part. Volitional movement of a body part involves several parts of the cortex. For example, the prefrontal cortex is where the decision to move the body part occurs, the pre-motor cortex then generates the particular instructions for performing the movement, and the motor cortex then uses these instructions to send the appropriate electrical pulses to the body part via the spinal cord. The loss of volitional movement of a body part is usually caused by damage to the motor cortex. Some of the following embodiments for generating the intended neural activity may locate the site on the cortex where the brain is recruiting neurons related to the functionality of the impaired body part even though the patient is incapable of moving it.
The passive movement of the impaired body part is expected to provide a good indication of the location in the cortex where the brain is performing neural activity that controls the impaired body part. Passively moving the impaired body part produces neural signals that travel through the spinal cord to the cortex. The neural signals then produce neural activity at a site in the brain that is associated with the function of the impaired body part. In one embodiment, this neural activity defines the “intended neural activity.” The site of the intended neural activity generated by the passive movement of the impaired body part correlates well with active movement of the impaired body part. Thus, by passively moving an impaired body part and monitoring the intended neural activity that occurs in response to the passive motion, the location of the intended neural activity allows one to select, in selection phase 114, the stimulation site for applying an electrical therapy or another type of therapy.
As suggested in
In the particular example of
In circumstances where neural activity occurs at multiple locations in response to moving the impaired body part, the selection phase 114 may further include selecting one or more of the areas of the brain exhibiting such neural activity as a stimulation site. In one particular embodiment, the selection phase 114 includes selecting a stimulation site from a plurality of potential stimulation sites exhibiting such neural activity that is contralateral to a damaged location of the brain and ipsilateral to an impaired body function. Hence, in the specific example of
Movement of the contralateral homotypic body part can be accomplished in a variety of ways. In some of the embodiments discussed above, the patient may have little or no volitional control over movement of an impaired body part, necessitating intervention by an operator or a device to move the impaired body part. Because the contralateral homotypic body part often will have largely unimpaired function, movement of the homotypic body part in the generating phase 140 may be volitional movement of the body part by the patient. For example, the patient may be requested to flex or otherwise move the fingers of the left hand. In another embodiment, the contralateral homotypic body part may be moved passively as discussed above in connection with
The diagnostic procedure 102 of
In another embodiment, a generating phase (not shown) may instead comprise volitional exercise of the actual impaired body function. For example, to enhance the ability to learn a particular task (e.g., playing a musical instrument or memorizing information), the neural activity may be monitored (in a manner analogous to the monitoring phase 142 of
The embodiment of the diagnostic procedure 102 shown in
In certain applications of the embodiment shown in
The diagnostic procedure 102 in
The embodiment of the diagnostic procedure 102 shown in
Another benefit of several embodiments of the diagnostic procedures described above with reference to
The monitoring phase 152 of this embodiment of the diagnostic procedure 102 involves measuring the response to the electrical stimulation that was applied to the cortex in the generating phase 150. The response can be detected using electrical sensors at the impaired body part or by detecting movement of the impaired body part. If no response is detected, then the particular area of the cortex to which the stimulation was applied is not likely the motor control area of the cortex associated with performing neural activity for the impaired body part. The diagnostic procedure 102 can accordingly further include a decision phase 153 in which the practitioner or a computer decides to apply stimulation to another area of the cortex by moving a TMS device to another location, or selecting another electrode configuration on the electrode array. If a response is detected at the impaired body part, then the area of the cortex to which the stimulation was applied is likely involved in performing the neural function for the impaired body part. The diagnostic procedure 102 in this embodiment can also decide to test alternate cortical stimulation regions or locations at the decision phase 153 even when a response to the stimulation is detected to further refine the area of the cortex that is performing the neural activity of the impaired body part. After testing one or, more typically, several different cortical stimulation locations, the diagnostic procedure 102 can proceed to the selection phase 154 in which the area of the cortex that provided a desired response in the impaired body part is selected as the site to apply therapeutic electrical stimulation. If the generating phase 150 generates neural activity at multiple locations of the brain, the selection phase 154 may comprise selecting a stimulation site from these multiple potential stimulation sites. In one particular embodiment, the selection phase 154 comprises selecting a stimulation site that is ipsilateral to an impaired body part and contralateral to a damaged location of the brain 200 that was formerly associated with the impaired body part.
An alternative embodiment of the diagnostic procedure 102 involves identifying a stimulation site at a second location of the brain where the neural activity has changed in response to a change in the neural-function of the patient. This embodiment of the method does not necessarily require that the intended neural activity be generated by peripherally actuating or stimulating a body part. For example, the brain can be scanned for neural activity associated with the impaired neural-function as a patient regains use of an affected limb or learns a task over a period of time. This embodiment, however, can also include peripherally generating the intended neural activity remotely from the brain explained above.
In still another embodiment, the diagnostic procedure 102 involves identifying a stimulation site at a location of the brain where the intended neural activity is developing to perform the neural-function. This embodiment is similar to the other embodiments of the diagnostic procedure 102, but it can be used to identify a stimulation site at (a) the normal region of the brain where the intended neural activity is expected to occur according to the functional organization of the brain and/or (b) a different region where the neural activity occurs because the brain is recruiting additional matter to perform the neural-function. This particular embodiment of the method involves monitoring neural activity at one or more locations where the neural activity occurs in response to the particular neural-function of interest. For example, to enhance the ability to learn a particular task (e.g., playing a musical instrument, memorizing, etc.), the neural activity can be monitored while a person performs the task or thinks about performing the task. The stimulation sites can be defined by the areas of the brain where the neural activity has the highest intensity, the greatest increases, and/or other parameters that indicate areas of the brain that are being used to perform the particular task.
Several embodiments of methods for enhancing neural activity in accordance with the invention are expected to provide lasting results that promote the desired neural-function. Before the present invention, electrical and magnetic stimulation techniques typically stimulated the normal locations of the brain where neural activity related to the neural-functions occurred according to the functional organization of the brain. Such conventional techniques, however, may not be effective because the neurons in the “normal locations” of the brain may not be capable of carrying out the neural activity because of brain damage, disease, disorder, and/or because of variations of the location specific to individual patients. Several embodiments of methods for enhancing neural activity in accordance with the invention overcome this drawback by identifying a stimulation site based on neuroplastic activity that appears to be related to the neural-function. By first identifying a location in the brain that is being recruited to perform the neural activity, it is expected that therapies (e.g., electrical, magnetic, genetic, biologic, and/or pharmaceutical) applied to this location will be more effective than conventional techniques. This is because the location that the brain is recruiting for the neural activity may not be the “normal location” where the neuro activity would normally occur according to the functional organization of the brain. Therefore, several embodiments of methods for enhancing neural activity in accordance with the invention are expected to provide lasting results because the therapies are applied to the portion of the brain where neural activity for carrying out the neural-function actually occurs in the particular patient.
2. Electrically Inducing Desired Neural Activity
The method 100 for effectuating a neural-function can also be used to induce neural activity in a region of the brain where such neural activity is not present. As opposed to the embodiments of the method 100 described above for enhancing existing neural activity, the embodiments of the method 100 for inducing neural activity initiate the neural activity at a stimulation site where it is estimated that neuroplasticity will occur. In this particular situation, an image of the brain seeking to locate where neuroplasticity is occurring may be similar to
A stimulation site may be identified by estimating where the brain will likely recruit neurons for performing the neural-function. In one embodiment, the location of the stimulation site is estimated by defining a region of the brain that is proximate to the normal location where neural activity related to the neural-function is generally present according to the functional organization of the brain. An alternative embodiment for locating the stimulation site includes determining where neuroplasticity has typically occurred in patients with similar symptoms. For example, if the brain typically recruits a second region of the cortex to compensate for a loss of neural activity in the normal region of the cortex, then the second region of the cortex can be selected as the stimulation site either with or without imaging the neural activity in the brain.
Several embodiments of methods for inducing neural activity in accordance with the invention are also expected to provide lasting results that initiate and promote a desired neural-function. By first estimating the location of a stimulation site where desired neuroplasticity is expected to occur, therapies applied to this location may be more effective than conventional therapies for reasons that are similar to those explained above regarding enhancing neural activity. Additionally, methods for inducing neural activity may be easier and less expensive to implement because they do not require generating neural activity and/or imaging the brain to determine where the intended neural activity is occurring before applying the therapy.
3. Applications of Methods for Electrically Stimulating Regions of the Brain
The foregoing methods for enhancing existing neural activity or inducing new neural activity are expected to be useful for many applications. As explained above, several embodiments of the method 100 involve determining an efficacious location of the brain to enhance or induce an intended neural activity that causes the desired neural-functions to occur. Additional therapies can also be implemented in combination with the electrical stimulation methods described above. Several specific applications using embodiments of electrical stimulation methods in accordance with the invention either alone or with adjunctive therapies will now be described, but it will be appreciated that the methods in accordance with the invention can be used in many additional applications.
a. General Applications
The embodiments of the electrical stimulation methods described above are expected to be particularly useful for rehabilitating a loss of mental functions, motor functions and/or sensory functions caused by damage to the brain. In a typical application, the brain has been damaged by a stroke or trauma (e.g., automobile accident). The extent of the particular brain damage can be assessed using functional MRI or another appropriate imaging technique as explained above with respect to
Several specific applications are expected to have a stimulation site in the cortex because neural activity in this part of the brain effectuates motor functions and/or sensory functions that are typically affected by a stroke or trauma. In these applications, the electrical stimulation can be applied directly to the pial surface of the brain or at least proximate to the pial surface (e.g., the dura mater, the fluid surrounding the cortex, or neurons within the cortex). Suitable devices for applying the electrical stimulation to the cortex are described in detail with reference to
The electrical stimulation methods can also be used with adjunctive therapies to rehabilitate damaged portions of the brain. In one embodiment, the electrical stimulation methods can be combined with behavioral therapy and/or drug therapies to rehabilitate an affected neural function. For example, if a stroke patient has lost the use of a limb, the patient can be treated by applying the electrical therapy to a stimulation site where the intended neural activity is present while the affected limb is also subject to physical therapy. An alternative embodiment can involve applying the electrical therapy to the stimulation site and chemically treating the patient using amphetamines or other suitable drugs.
The embodiments of the electrical stimulation methods described above are also expected to be useful for treating brain diseases, such as Alzheimer's, Parkinson's, and other brain diseases. In this application, the stimulation site can be identified by monitoring the neural activity using functional MRI or other suitable imaging techniques over a period of time to determine where the brain is recruiting material to perform the neural activity that is being affected by the disease. It may also be possible to identify the stimulation site by having the patient try to perform an act that the particular disease has affected, and monitoring the brain to determine whether any response neural activity is present in the brain. After identifying where the brain is recruiting additional matter, the electrical stimulation can be applied to this portion of the brain. It is expected that electrically stimulating the regions of the brain that have been recruited to perform the neural activity which was affected by the disease will assist the brain in offsetting the damage caused by the disease.
The embodiments of the electrical stimulation methods described above are also expected to be useful for treating neurological disorders, such as depression, passive-aggressive behavior, weight control, and other disorders. In these applications, the electrical stimulation can be applied to a stimulation site in the cortex or another suitable part of the brain where neural activity related to the particular disorder is present. The embodiments of electrical stimulation methods for carrying out the particular therapy can be adapted to either increase or decrease the particular neural activity in a manner that produces the desired results. For example, an amputee may feel phantom sensations associated with the amputated limb. This phenomenon can be treated by applying an electrical pulse that reduces the phantom sensations. The electrical therapy can be applied so that it will modulate the ability of the neurons in that portion of the brain to execute sensory functions.
b. Pulse Forms and Potentials
The electrical stimulation methods in accordance with the invention can use several different pulse forms to facilitate or effectuate the desired neuroplasticity.
The pulses can be a bi-phasic or monophasic stimulus that is applied to achieve a desired potential in a sufficient percentage of a population of neurons at the stimulation site. In one embodiment, the pulse form has a frequency of approximately 2-1000 Hz, but the frequency may be particularly useful in the range of approximately 40-200 Hz. For example, initial clinical trials are expected to use a frequency of approximately 50-100 Hz. The pulses can also have pulse widths of approximately 10 μs-100 ms, or more specifically the pulse width can be approximately 20-200 μs. For example, a pulse width of 50-100 μs may produce beneficial results.
It is expected that one particularly useful application of the invention involves enhancing or inducing neuroplasticity by raising the membrane potential of neurons to bring the neurons closer to the threshold level for firing an action potential. Because the stimulation raises the membrane potential of the neurons, it is expected that these neurons are more likely to “fire” an action potential in response to excitatory input at a lower level.
The actual electrical potential applied to electrodes implanted in the brain to achieve a subthreshold potential stimulation will vary according to the individual patient, the type of therapy, the type of electrodes, and other factors. In general, the pulse form of the electrical stimulation (e.g., the frequency, pulse width, wave form, and voltage potential) is selected to raise the potential in a sufficient number neurons at the stimulation site to a level that is less than a threshold potential for a statistical portion of the neurons in the population. The pulse form, for example, can be selected so that the applied voltage of the stimulus achieves a change in the potential of approximately 10%-95%, and more specifically of 60%-80%, of the difference between the unstimulated resting potential and the threshold potential.
In one specific example of a subthreshold application for treating a patient's hand, electrical stimulation is not initially applied to the stimulation site. Although physical therapy related to the patient's hand may cause some activation of a particular population of neurons that is known to be involved in “hand function,” only a low level of activation might occur because physical therapy only produces a low level of action potential generation in that population of neurons. However, when the subthreshold electrical stimulation is applied, the membrane potentials of the neurons in the stimulated population are elevated. These neurons now are much closer to the threshold for action potential formation such that when the same type of physical therapy is given, this population of cells will have a higher level of activation because these cells are more likely to fire action potentials.
Subthreshold stimulation may produce better results than simply stimulating the neurons with sufficient energy levels to exceed the threshold for action potential formation. One aspect of subthreshold stimulation is to increase the probability that action potentials will occur in response to the ordinary causes of activation—such as behavioral therapy. This will allow the neurons in this functional network to become entrained together, or “learn” to become associated with these types of activities. If neurons are given so much electricity that they continually fire action potentials without additional excitatory inputs (suprathreshold stimulation), this will create “noise” and disorganization that will not likely cause improvement in function. In fact, neurons that are “overdriven” soon deplete their neurotransmitters and effectively become silent.
The application of a subthreshold stimulation is very different than suprathreshold stimulation. Subthreshold stimulation in accordance with several embodiments of the invention, for example, does not intend to directly make neurons fire action potentials with the electrical stimulation in a significant population of neurons at the stimulation site. Instead, subthreshold stimulation attempts to decrease the “activation energy” required to activate a large portion of the neurons at the stimulation site. As such, subthreshold stimulation in accordance with certain embodiments of the invention is expected to increase the probability that the neurons will fire in response to the usual intrinsic triggers, such as trying to move a limb, physical therapy, or simply thinking about movement of a limb, etc. Moreover, coincident stimulation associated with physical therapy is expected to increase the probability that the action potentials that are occurring with an increased probability due to the subthreshold stimulation will be related to meaningful triggers, and not just “noise.”
The stimulus parameters set forth above, such as a frequency selection of approximately 50-100 Hz and an amplitude sufficient to achieve an increase of 60% to 80% of the difference between the potential and the threshold potential are specifically selected so that they will increase the resting membrane potential of the neurons, thereby increasing the likelihood that they will fire action potentials, without directly causing action potentials in most of the neuron population. In addition, and as explained in more detail below with respect to
1. Implantable Stimulation Apparatus with Integrated Pulse Systems
The embodiment of the stimulation apparatus 600 shown in
Several embodiments of the stimulation apparatus 600 are expected to be more effective than existing transcranial electrical stimulation devices and transcranial magnetic stimulation devices. It will be appreciated that much of the power required for transcranial therapies is dissipated in the scalp and skull before it reaches the brain. In contrast to conventional transcranial stimulation devices, the stimulation apparatus 600 is implanted so that the electrodes are at least proximate to the pial surface of the brain 708. Several embodiments of methods in accordance with the invention can use the stimulation apparatus 600 to apply an electrical therapy directly to the pia mater 708, the dura mater 706, and/or another portion of the cortex 709 at significantly lower power levels than existing transcranial therapies. For example, a potential of approximately 1 mV to 10 V can be applied to the electrodes 660; in many instances a potential of 100 mV to 5 V can be applied to the electrodes 660 for selected applications. It will also be appreciated that other potentials can be applied to the electrodes 660 of the stimulation apparatus 600 in accordance with other embodiments of the invention.
Selected embodiments of the stimulation apparatus 600 are also capable of applying stimulation to a precise stimulation site. Again, because the stimulation apparatus 600 positions the electrodes 660 at least proximate to the pial surface 708, precise levels of stimulation with good pulse shape fidelity will be accurately transmitted to the stimulation site in the brain. It will be appreciated that transcranial therapies may not be able to apply stimulation to a precise stimulation site because the magnetic and electrical properties of the scalp and skull may vary from one patient to another such that an identical stimulation by the transcranial device may produce a different level of stimulation at the neurons in each patient. Moreover, the ability to focus the stimulation to a precise area is hindered by delivering the stimulation transcranially because the scalp, skull and dura all diffuse the energy from a transcranial device. Several embodiments of the stimulation apparatus 600 overcome this drawback because the electrodes 660 are positioned under the skull 700 such that the pulses generated by the stimulation apparatus 600 are not diffused by the scalp 702 and skull 700.
2. Integrated Pulse Systems for Implantable Stimulation Apparatus
The pulse system 630 shown in
2. Implantable Stimulation Apparatus with External Pulse Systems
The stimulation apparatus 3100, however, does not have an internal pulse system carried by the portion of the device that is implanted in the skull 700 of the patient 500. The stimulation apparatus 3100 receives electrical pulses from an external pulse system 3130. The external pulse system 3130 can have an electrical connector 3132 with a plurality of contacts 3134 configured to engage the contacts within the receptacle 3120. The external pulse system 3130 can also have a power supply, controller, pulse generator, and pulse transmitter to generate the electrical pulses. In operation, the external pulse system 3130 sends electrical pulses to the stimulation apparatus 3100 via the connector 3132, the receptacle 3120, and the lead line 3124.
3. Alternate Embodiments of Implantable Stimulation Apparatus
From the foregoing, it will be appreciated that specific embodiments of the invention have been described herein for purposes of illustration, but that various modifications may be made without deviating from the spirit and scope of the invention. Accordingly, the invention is not limited except as by the appended claims. All of the U.S. Patents, U.S. Patent applications, and other references noted above are incorporated herein by reference.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3650276 *||25 Mar 1969||21 Mar 1972||Inst Demedicina Si Farmacie||Method and apparatus, including a flexible electrode, for the electric neurostimulation of the neurogenic bladder|
|US4140133 *||26 Apr 1977||20 Feb 1979||Moskovsky Oblastnoi Nauchno-Issledovatelsky Institut Akusherstva I Ginekolog Ii||Device for pulse current action on central nervous system|
|US4542752 *||22 Apr 1983||24 Sep 1985||Cordis Corporation||Implantable device having porous surface with carbon coating|
|US4607639 *||18 May 1984||26 Aug 1986||Regents Of The University Of California||Method and system for controlling bladder evacuation|
|US4646744 *||29 Jun 1984||3 Mar 1987||Zion Foundation||Method and treatment with transcranially applied electrical signals|
|US4844075 *||7 May 1986||4 Jul 1989||Pain Suppression Labs, Inc.||Transcranial stimulation for the treatment of cerebral palsy|
|US4865048 *||31 Dec 1987||12 Sep 1989||Eckerson Harold D||Method and apparatus for drug free neurostimulation|
|US5002053 *||21 Apr 1989||26 Mar 1991||University Of Arkansas||Method of and device for inducing locomotion by electrical stimulation of the spinal cord|
|US5031618 *||7 Mar 1990||16 Jul 1991||Medtronic, Inc.||Position-responsive neuro stimulator|
|US5092835 *||6 Jul 1990||3 Mar 1992||Schurig Janet L S||Brain and nerve healing power apparatus and method|
|US5143089 *||1 May 1990||1 Sep 1992||Eckhard Alt||Assembly and method of communicating electrical signals between electrical therapeutic systems and body tissue|
|US5169384 *||16 Aug 1991||8 Dec 1992||Bosniak Stephen L||Apparatus for facilitating post-traumatic, post-surgical, and/or post-inflammatory healing of tissue|
|US5215086 *||3 May 1991||1 Jun 1993||Cyberonics, Inc.||Therapeutic treatment of migraine symptoms by stimulation|
|US5304206 *||18 Nov 1991||19 Apr 1994||Cyberonics, Inc.||Activation techniques for implantable medical device|
|US5358513 *||9 Dec 1992||25 Oct 1994||Medtronic, Inc.||Parameter selection and electrode placement of neuromuscular electrical stimulation apparatus|
|US5370672 *||30 Oct 1992||6 Dec 1994||The Johns Hopkins University||Computer-controlled neurological stimulation system|
|US5411540 *||3 Jun 1993||2 May 1995||Massachusetts Institute Of Technology||Method and apparatus for preferential neuron stimulation|
|US5417719 *||25 Aug 1993||23 May 1995||Medtronic, Inc.||Method of using a spinal cord stimulation lead|
|US5537512 *||7 Feb 1995||16 Jul 1996||Northrop Grumman Corporation||Neural network elements|
|US5540736 *||21 Dec 1994||30 Jul 1996||Haimovich; Yechiel||Transcranial electrostimulation apparatus having two electrode pairs and independent current generators|
|US5549655 *||21 Sep 1994||27 Aug 1996||Medtronic, Inc.||Method and apparatus for synchronized treatment of obstructive sleep apnea|
|US5591216 *||19 May 1995||7 Jan 1997||Medtronic, Inc.||Method for treatment of sleep apnea by electrical stimulation|
|US5593432 *||23 Jun 1993||14 Jan 1997||Neuroware Therapy International, Inc.||Method for neurostimulation for pain alleviation|
|US5628317 *||4 Apr 1996||13 May 1997||Medtronic, Inc.||Ultrasonic techniques for neurostimulator control|
|US5683422 *||25 Apr 1996||4 Nov 1997||Medtronic, Inc.||Method and apparatus for treating neurodegenerative disorders by electrical brain stimulation|
|US5702429 *||4 Apr 1996||30 Dec 1997||Medtronic, Inc.||Neural stimulation techniques with feedback|
|US5711316 *||30 Apr 1996||27 Jan 1998||Medtronic, Inc.||Method of treating movement disorders by brain infusion|
|US5713922 *||25 Apr 1996||3 Feb 1998||Medtronic, Inc.||Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain|
|US5713923 *||13 May 1996||3 Feb 1998||Medtronic, Inc.||Techniques for treating epilepsy by brain stimulation and drug infusion|
|US5716377 *||25 Apr 1996||10 Feb 1998||Medtronic, Inc.||Method of treating movement disorders by brain stimulation|
|US5735814 *||30 Apr 1996||7 Apr 1998||Medtronic, Inc.||Techniques of treating neurodegenerative disorders by brain infusion|
|US5752979 *||1 Nov 1996||19 May 1998||Medtronic, Inc.||Method of controlling epilepsy by brain stimulation|
|US5782798 *||26 Jun 1996||21 Jul 1998||Medtronic, Inc.||Techniques for treating eating disorders by brain stimulation and drug infusion|
|US5792186 *||30 Apr 1997||11 Aug 1998||Medtronic, Inc.||Method and apparatus for treating neurodegenerative disorders by electrical brain stimulation|
|US5797970 *||4 Sep 1996||25 Aug 1998||Medtronic, Inc.||System, adaptor and method to provide medical electrical stimulation|
|US5814014 *||29 Jul 1997||29 Sep 1998||Medtronic Incorporated||Techniques of treating neurodegenerative disorders by brain infusion|
|US5814092 *||8 May 1997||29 Sep 1998||Medtronic Inc.||Neural stimulation techniques with feedback|
|US5824021 *||22 Jul 1997||20 Oct 1998||Medtronic Inc.||Method and apparatus for providing feedback to spinal cord stimulation for angina|
|US5832932 *||30 Apr 1997||10 Nov 1998||Medtronic, Inc.||Method of treating movement disorders by brain infusion|
|US5833709 *||30 Apr 1997||10 Nov 1998||Medtronic, Inc.||Method of treating movement disorders by brain stimulation|
|US5843148 *||27 Sep 1996||1 Dec 1998||Medtronic, Inc.||High resolution brain stimulation lead and method of use|
|US5843150 *||8 Oct 1997||1 Dec 1998||Medtronic, Inc.||System and method for providing electrical and/or fluid treatment within a patient's brain|
|US5885976 *||25 Nov 1997||23 Mar 1999||Sandyk; Reuven||Methods useful for the treatment of neurological and mental disorders related to deficient serotonin neurotransmission and impaired pineal melatonin functions|
|US5886769 *||18 May 1998||23 Mar 1999||Zolten; A. J.||Method of training and rehabilitating brain function using hemi-lenses|
|US5893883 *||30 Apr 1997||13 Apr 1999||Medtronic, Inc.||Portable stimulation screening device for screening therapeutic effect of electrical stimulation on a patient user during normal activities of the patient user|
|US5904916 *||5 Mar 1996||18 May 1999||Hirsch; Alan R.||Use of odorants to alter learning capacity|
|US5913882 *||5 Jun 1998||22 Jun 1999||Medtronic Inc.||Neural stimulation techniques with feedback|
|US5925070 *||10 Mar 1997||20 Jul 1999||Medtronic, Inc.||Techniques for adjusting the locus of excitation of electrically excitable tissue|
|US5938688 *||4 Dec 1997||17 Aug 1999||Cornell Research Foundation, Inc.||Deep brain stimulation method|
|US5938689 *||1 May 1998||17 Aug 1999||Neuropace, Inc.||Electrode configuration for a brain neuropacemaker|
|US5941906 *||15 Oct 1997||24 Aug 1999||Medtronic, Inc.||Implantable, modular tissue stimulator|
|US5964794 *||20 Mar 1997||12 Oct 1999||Biotronik Mess- Und Therapiegeraete Gmbh & Co. Ingenieurbuero Berlin||Implantable stimulation electrode|
|US5978702 *||24 Oct 1997||2 Nov 1999||Medtronic, Inc.||Techniques of treating epilepsy by brain stimulation and drug infusion|
|US5983140 *||2 Nov 1998||9 Nov 1999||Shriners Hospitals For Children||Portable functional electrical stimulation (FES) system for upper or lower extremity applications|
|US6006124 *||1 May 1998||21 Dec 1999||Neuropace, Inc.||Means and method for the placement of brain electrodes|
|US6011996 *||20 Jan 1998||4 Jan 2000||Medtronic, Inc||Dual electrode lead and method for brain target localization in functional stereotactic brain surgery|
|US6016449 *||27 Oct 1997||18 Jan 2000||Neuropace, Inc.||System for treatment of neurological disorders|
|US6018682 *||30 Apr 1998||25 Jan 2000||Medtronic, Inc.||Implantable seizure warning system|
|US6021352 *||26 Jun 1996||1 Feb 2000||Medtronic, Inc,||Diagnostic testing methods and apparatus for implantable therapy devices|
|US6026326 *||13 Jan 1997||15 Feb 2000||Medtronic, Inc.||Apparatus and method for treating chronic constipation|
|US6042579 *||30 Apr 1997||28 Mar 2000||Medtronic, Inc.||Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain|
|US6052624 *||7 Jan 1999||18 Apr 2000||Advanced Bionics Corporation||Directional programming for implantable electrode arrays|
|US6055456 *||29 Apr 1999||25 Apr 2000||Medtronic, Inc.||Single and multi-polar implantable lead for sacral nerve electrical stimulation|
|US6057847 *||9 May 1997||2 May 2000||Jenkins; Barry||System and method of image generation and encoding using primitive reprojection|
|US6058331 *||27 Apr 1998||2 May 2000||Medtronic, Inc.||Apparatus and method for treating peripheral vascular disease and organ ischemia by electrical stimulation with closed loop feedback control|
|US6060048 *||2 Jun 1995||9 May 2000||New York University||Method for transplanting cells into the brain and therapeutic uses therefor|
|US6061593 *||24 Apr 1998||9 May 2000||Neuropace, Inc.||EEG d-c voltage shift as a means for detecting the onset of a neurological event|
|US6104956 *||30 May 1997||15 Aug 2000||Board Of Trustees Of Southern Illinois University||Methods of treating traumatic brain injury by vagus nerve stimulation|
|US6104960 *||13 Jul 1998||15 Aug 2000||Medtronic, Inc.||System and method for providing medical electrical stimulation to a portion of the nervous system|
|US6122548 *||7 Jul 1999||19 Sep 2000||Medtronic, Inc.||System and method for preventing cross-conduction in a human-implantable dual channel neurostimulator|
|US6126657 *||17 Jul 1997||3 Oct 2000||Somnus Medical Technologies, Inc.||Apparatus for treatment of air way obstructions|
|US6128537 *||1 May 1997||3 Oct 2000||Medtronic, Inc||Techniques for treating anxiety by brain stimulation and drug infusion|
|US6128538 *||29 Nov 1999||3 Oct 2000||Neuropace, Inc.||Means and method for the treatment of neurological disorders|
|US6134474 *||15 Jan 2000||17 Oct 2000||Neuropace, Inc.||Responsive implantable system for the treatment of neurological disorders|
|US6152143 *||3 Apr 1998||28 Nov 2000||Somnus Medical Technologies, Inc.||Method for treatment of air way obstructions|
|US6161044 *||23 Nov 1998||12 Dec 2000||Synaptic Corporation||Method and apparatus for treating chronic pain syndromes, tremor, dementia and related disorders and for inducing electroanesthesia using high frequency, high intensity transcutaneous electrical nerve stimulation|
|US6161045 *||1 Jun 1999||12 Dec 2000||Neuropace, Inc.||Method for determining stimulation parameters for the treatment of epileptic seizures|
|US6221908 *||31 Dec 1998||24 Apr 2001||Scientific Learning Corporation||System for stimulating brain plasticity|
|US6353754 *||24 Apr 2000||5 Mar 2002||Neuropace, Inc.||System for the creation of patient specific templates for epileptiform activity detection|
|US6354299 *||30 Jun 2000||12 Mar 2002||Neuropace, Inc.||Implantable device for patient communication|
|US6356786 *||20 Jan 2000||12 Mar 2002||Electrocore Techniques, Llc||Method of treating palmar hyperhydrosis by electrical stimulation of the sympathetic nervous chain|
|US6360122 *||2 Aug 2000||19 Mar 2002||Neuropace, Inc.||Data recording methods for an implantable device|
|US6405079 *||22 Sep 2000||11 Jun 2002||Mehdi M. Ansarinia||Stimulation method for the dural venous sinuses and adjacent dura for treatment of medical conditions|
|US6427086 *||21 Apr 2000||30 Jul 2002||Neuropace, Inc.||Means and method for the intracranial placement of a neurostimulator|
|US6459936 *||17 Aug 2001||1 Oct 2002||Neuropace, Inc.||Methods for responsively treating neurological disorders|
|US6466822 *||5 Apr 2000||15 Oct 2002||Neuropace, Inc.||Multimodal neurostimulator and process of using it|
|US6473639 *||2 Mar 2000||29 Oct 2002||Neuropace, Inc.||Neurological event detection procedure using processed display channel based algorithms and devices incorporating these procedures|
|US6480743 *||24 Sep 2001||12 Nov 2002||Neuropace, Inc.||System and method for adaptive brain stimulation|
|US6597954 *||28 Nov 2000||22 Jul 2003||Neuropace, Inc.||System and method for controlling epileptic seizures with spatially separated detection and stimulation electrodes|
|US6959215 *||17 Jul 2003||25 Oct 2005||Northstar Neuroscience, Inc.||Methods for treating essential tremor|
|US20020028072 *||23 Aug 2001||7 Mar 2002||Ritsuo Kashiyama||Camera having illumination device and control function for same|
|US20020099412 *||12 Mar 2002||25 Jul 2002||Neuropace, Inc.||Methods for using an implantable device for patient communication|
|US20020169485 *||12 Apr 2002||14 Nov 2002||Neuropace, Inc.||Differential neurostimulation therapy driven by physiological context|
|US20060004423 *||9 Sep 2005||5 Jan 2006||Boveja Birinder R||Methods and systems to provide therapy or alleviate symptoms of chronic headache, transformed migraine, and occipital neuralgia by providing rectangular and/or complex electrical pulses to occipital nerves|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7672730||24 Jun 2003||2 Mar 2010||Advanced Neuromodulation Systems, Inc.||Methods and apparatus for effectuating a lasting change in a neural-function of a patient|
|US7684866||2 Aug 2004||23 Mar 2010||Advanced Neuromodulation Systems, Inc.||Apparatus and methods for applying neural stimulation to a patient|
|US7729773||18 Oct 2006||1 Jun 2010||Advanced Neuromodualation Systems, Inc.||Neural stimulation and optical monitoring systems and methods|
|US7742820||18 Jul 2006||22 Jun 2010||Advanced Neuromodulation Systems, Inc.||Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects|
|US7756584||27 Sep 2002||13 Jul 2010||Advanced Neuromodulation Systems, Inc.||Methods and apparatus for effectuating a lasting change in a neural-function of a patient|
|US7831305||15 Oct 2002||9 Nov 2010||Advanced Neuromodulation Systems, Inc.||Neural stimulation system and method responsive to collateral neural activity|
|US7869867||27 Oct 2006||11 Jan 2011||Cyberonics, Inc.||Implantable neurostimulator with refractory stimulation|
|US7869885||28 Apr 2006||11 Jan 2011||Cyberonics, Inc||Threshold optimization for tissue stimulation therapy|
|US7908009||18 Jul 2006||15 Mar 2011||Advanced Neuromodulation Systems, Inc.||Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects|
|US7917225||18 Jul 2006||29 Mar 2011||Advanced Neuromodulation Systems, Inc.||Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects|
|US8452387||20 Sep 2010||28 May 2013||Flint Hills Scientific, Llc||Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex|
|US8571643||16 Sep 2010||29 Oct 2013||Flint Hills Scientific, Llc||Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex|
|US8945006||24 Feb 2014||3 Feb 2015||Flunt Hills Scientific, LLC||Detecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis|
|US8948855||21 May 2013||3 Feb 2015||Flint Hills Scientific, Llc||Detecting and validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex|
|US9020582||30 Sep 2013||28 Apr 2015||Flint Hills Scientific, Llc||Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex|
|US9050469||24 Nov 2004||9 Jun 2015||Flint Hills Scientific, Llc||Method and system for logging quantitative seizure information and assessing efficacy of therapy using cardiac signals|
|US9108041||25 Nov 2013||18 Aug 2015||Dignity Health||Microburst electrical stimulation of cranial nerves for the treatment of medical conditions|
|US20040088024 *||24 Jun 2003||6 May 2004||Firlik Andrew D.||Methods and apparatus for effectuating a lasting change in a neural-function of a patient|
|US20040102828 *||18 Apr 2003||27 May 2004||Lowry David Warren||Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography|
|US20040111127 *||10 Dec 2002||10 Jun 2004||Gliner Bradford Evan||Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders|
|US20040158298 *||15 Oct 2001||12 Aug 2004||Gliner Bradford Evan||Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators|
|US20040181263 *||9 Dec 2003||16 Sep 2004||Jeffrey Balzer||System and method for treating Parkinson's Disease and other movement disorders|
|US20050021105 *||6 Aug 2004||27 Jan 2005||Firlik Andrew D.||Methods and apparatus for effectuating a change in a neural-function of a patient|
|US20050021107 *||6 Aug 2004||27 Jan 2005||Firlik Andrew D.||Methods and apparatus for effectuating a lasting change in a neural-function of a patient|
|US20050021118 *||25 Jun 2004||27 Jan 2005||Chris Genau||Apparatuses and systems for applying electrical stimulation to a patient|
|US20050033378 *||9 Dec 2003||10 Feb 2005||Sheffield Warren Douglas||Methods for treating and/or collecting information regarding neurological disorders, including language disorders|
|US20050070971 *||2 Aug 2004||31 Mar 2005||Brad Fowler||Apparatus and methods for applying neural stimulation to a patient|
|US20050075679 *||7 May 2004||7 Apr 2005||Gliner Bradford E.||Methods and apparatuses for treating neurological disorders by electrically stimulating cells implanted in the nervous system|
|US20050075680 *||15 Jul 2004||7 Apr 2005||Lowry David Warren||Methods and systems for intracranial neurostimulation and/or sensing|
|US20090299418 *||23 Aug 2005||3 Dec 2009||Brainsgate Ltd.||Concurrent bilateral spg modulation|
|US20130096640 *||12 Oct 2012||18 Apr 2013||Marc Possover||Method for recovering body functions|
|International Classification||A61N1/375, A61N1/05, A61N1/36|
|Cooperative Classification||A61N1/0534, A61N1/361, A61N1/3756, A61N1/36025, A61N1/36082, A61N1/36014, A61N1/0539, A61N1/36017, A61N1/375, A61N1/0531|
|European Classification||A61N1/36Z3F, A61N1/36Z, A61N1/375, A61N1/05K1C, A61N1/36E, A61N1/05K1S, A61N1/36, A61N1/36E2, A61N1/36Z3E, A61N1/36E6, A61N1/05K1D|
|12 Jun 2009||AS||Assignment|
Owner name: ADVANCED NEUROMODULATION SYSTEMS, INC.,TEXAS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NORTHSTAR NEUROSCIENCE, INC.;REEL/FRAME:022813/0542
Effective date: 20090521